BackStryker Overview
Stryker Corp.

Stryker Target Price

Where could SYK trade next? Consensus target price: $380.

Get informed when a big investor buys or sells

+ Follow

Share Price

$303.13

Average Target Price

$378.0024.7% upside

10 analysts in the last 4 months

High: $420 | Low: $350

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-31RBC CapitalShagun Singh$42038.6% upsideOpen
2026-07-31Raymond James$37022.1% upsideOpen
2026-07-31BTIGRyan Zimmerman$35818.1% upsideOpen
2026-07-31Piper Sandler$39028.7% upsideOpen
2026-07-31Wolfe Research$37523.7% upsideOpen
2026-07-13BTIG$37122.4% upsideOpen
2026-07-09Argus Research$37022.1% upsideOpen
2026-07-08BMO Capital$36921.7% upsideOpen
2026-07-06Evercore ISI$35015.5% upsideOpen
2026-06-05Leerink PartnersMike Kratky$40734.3% upsideOpen
2026-05-04Truist FinancialRichard Newitter$3308.9% upsideOpen
2026-05-04BarclaysMatt Miksic$39430% upsideOpen
2026-05-01Goldman SachsDavid Roman$36119.1% upsideOpen
2026-05-01Bernstein$41035.3% upsideOpen
2026-05-01Robert W. Baird$38527% upsideOpen
2026-05-01Evercore ISI$35517.1% upsideOpen
2026-05-01BTIG$37925% upsideOpen
2026-05-01Needham$41837.9% upsideOpen
2026-05-01Deutsche Bank$3153.9% upsideOpen
2026-03-04JefferiesMatthew Taylor$46553.4% upsideOpen
2026-02-24UBS$40032% upsideOpen
2026-02-02Barclays$46954.7% upsideOpen
2026-01-30NeedhamMike Matson$45449.8% upsideOpen
2026-01-30Robert W. Baird$43744.2% upsideOpen
2026-01-30BTIGRyan Zimmerman$41235.9% upsideOpen
2026-01-09BernsteinLee Hambright$46553.4% upsideOpen
2026-01-09Goldman Sachs$39931.6% upsideOpen
2026-01-06Raymond James$41837.9% upsideOpen
2026-01-05Evercore ISI$39028.7% upsideOpen
2025-11-14Truist FinancialRichard Newitter$40032% upsideOpen
2025-11-14RBC CapitalShagun Singh$43543.5% upsideOpen
2025-11-14NeedhamMike Matson$44847.8% upsideOpen
2025-11-03Truist Financial$39229.3% upsideOpen
2025-10-31Evercore ISI$40533.6% upsideOpen
2025-10-15Truist Financial$40734.3% upsideOpen
2025-10-13UBS$40834.6% upsideOpen
2025-10-07Evercore ISI$41035.3% upsideOpen
2025-09-18Redburn Partners$42038.6% upsideOpen
2025-08-04Truist Financial$41536.9% upsideOpen
2025-05-05BernsteinLee Hambright$45048.5% upsideOpen
2025-04-14BTIGRyan Zimmerman$40332.9% upsideOpen
2025-03-04Goldman Sachs$42239.2% upsideOpen
2025-02-03Argus ResearchDavid Toung$45048.5% upsideOpen
2024-12-18Truist FinancialRichard Newitter$40934.9% upsideOpen
2024-12-02Morgan StanleyPatrick Wood$44546.8% upsideOpen
2024-10-31CitigroupJoanne Wuensch$41135.6% upsideOpen
2024-10-30Piper SandlerMatt O'Brien$42038.6% upsideOpen
2024-10-30Truist FinancialRichard Newitter$38025.4% upsideOpen
2024-10-30Canaccord GenuityKyle Rose$40032% upsideOpen
2024-10-30BTIGRyan Zimmerman$39430% upsideOpen

Stryker (SYK) FAQ

Stryker posts a target price of $380. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $380 for SYK means covering analysts, on average, see the stock 24.7% upside of $303.13 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for SYK's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Stryker's other metric pages and overview cover the third.

Judging Stryker against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $380 here, then scan peer and history charts to see if the gap is persistent.